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Introduction
Vertebral body compression fractures (VBCFs) are a com-
mon and often debilitating expression of osteoporosis. Pa-
tients may suffer from acute episodes of pain as well as
chronic pain problems due to the resulting spinal deformi-
ties, as the natural history of osteoporotic vertebral frac-
tures is often accompanied by kyphotic collapse of the af-
fected segment. Osteoporotic kyphosis has an adverse ef-
fect on the mobility of patients, quality of life and even
the rate of survival [3, 11, 19]. Also, the risk of pain and
disability increases progressively with the number and
severity of vertebral deformities [18].
Conservative management of VBCFs includes anal-
gesics, bed rest, and external bracing. However, some pa-
tients do not respond to these therapies in either terms of
pain relief or progression of deformity. More invasive sur-
gical procedures such as internal fixation and stabilisation
are not the optimal treatment for the majority of patients
due to their usually advanced age and associated comor-
bidities, as well as technical factors such as limited hold-
ing power of implants in osteoporotic bone [24]. An ideal
therapy should address both fracture-related pain and the
associated spinal deformity in a minimally invasive fash-
ion.
During the last few years, percutaneous cement aug-
mentation of the fractured vertebral bodies (vertebroplasty)
has been highly advocated as a treatment for focal back
pain on the basis of osteoporotic VBCFs [5]. Rapid re-
gression of pain has been found in 80–90% of treated pa-
tients, with a long-lasting effect in a similar rate of pa-
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tients [1, 6, 9, 16]. However, vertebroplasty does not ad-
dress the associated spinal malalignement as it “freezes”
the deformity.
Kyphoplasty is a minimally invasive procedure that
aims to address both the fracture pain and the kyphotic de-
formity. During the procedure, tamps are positioned in-
side the vertebral body through a working cannula under
fluoroscopic control. The tamps are inflated, thereby lift-
ing the endplates and creating a cavity, which, following
tamp removal, is filled with bone cement to maintain re-
duction. In comparison to vertebroplasty, more viscous
cement may be introduced with less pressure, thereby de-
creasing the risk of cement extrusions [17].
A few very short-term studies have reported on clinical
results after kyphoplasty, indicating significant pain relief
in combination with an initial reduction of local bony
kyphosis by 33–50% [7, 14]. There has been little investi-
gation into whether pain relief and particularly reduction
of vertebral height are lasting effects. The current study
reports on our experience and the one-year results in 27
kyphoplasty procedures (24 patients) for osteoporotic
VBCFs.
Materials and methods
Technique
Patients were positioned prone on a radiolucent operating table.
Under image intensifier control, eight-gauge 6-inch bone marrow
biopsy needles (Manan Trapsystem, MDTech, Gainesville, FL,
USA) were percutaneously placed through stab incisions into the
fractured vertebral body. After transpedicular positioning, the nee-
dles were exchanged over a guidewire for a working cannula.
Inflatable bone tamps (Kyphon, Wezembeek-Oppem, Belgium)
were then placed into the vertebral bodies bilaterally. Inflation of
the balloons was controlled radiologically and by manometric pa-
rameters until the vertebral body height was restored or a pressure
of 300psi was reached (maximum certified pressure of balloons).
After deflation and withdrawal of the balloons, the remaining ver-
tebral body cavity was slowly filled under fluoroscopic control
with PMMA cement (Palacos E-flow, Essex Chemie) correspond-
ing to the combined volume of the inflated balloons.
After the cement had hardened, the working cannulas were re-
moved and the stab incisions closed. After recovery from anaes-
thesia, patients were allowed to mobilise according to their com-
plaints without any external bracing. Any cement leaks from the
vertebral bodies were recorded at surgery or on post-operative ra-
diographs.
Patients
The study included 24 patients (12 male, 12 female) with a follow-
up of one year. Overall, 27 vertebral bodies were augmented
(Table 1). The average age of the patients was 65.5 years (range
34–79 years). Twenty interventions were performed under intuba-
tion, and 4 patients were operated on with local anaesthetic in
combination with IV sedation. As the cases described represent
our early experience with this technique, we usually recommended
surgery under general anaesthesia.
Indications for the intervention were osteoporotic VBCFs caus-
ing focal pain with a kyphosis of 10° minimum or an increase of
deformity under initial mobilisation. Most patients did not have
any further imaging (CT, MRI, bone scan) prior to the interven-
tion. Several patients could not recall a specific incident as the be-
ginning of their focal pain, and could only give an estimate (e.g. 
40 days). In one case (no. 5, SH) the fracture was classified as
“old” (>180 days).
Standing films were used to measure kyphosis of the fractured
vertebral body as the angulation between both endplates. In some
patients, pre-op standing films could not be obtained due to their
pain. In these cases measurements were taken from the available
supine films. Pre-op films were compared to controls after 2–3
months, 5–6 months, and after one year.
After defining the anatomic landmarks in collaboration, the mea-
surements were taken independently by two different observers
(their average serving as the final result). The interobserver reli-
ability was assessed using the Kappa test with a 0.81 agreement.
The focal back pain in all patients was determined by VAS scores
(from 0 “no pain” to 10 “worst imaginable pain”) pre-operatively
and at the follow-up investigations.
Statistics
Multiple regression analysis was conducted to determine the rela-
tive importance of the possible independent factors (age, gender,
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Table 1 Data of the treated patients: initials, age of the patient,
sex, level treated, age of the fracture (pre-operative symptoms),
pre-operative vertebral kyphosis, reduction achieved, and correc-
tion in percent
No Pat Age Sex Level Age of Kyph Red Red 
fracture pre-op (°) %
(days) (°)
1 WY 72 F T10 60 10 0 0
2 WY 72 F L2 60 11 4 36
3 HE 62 M T7 40 17 8 47
4 HE 62 M T10 40 21 8 38
5 SH 77 M T12 >180 17 3 18
6 StH 78 F L1 40 11 1 9
7 StH 78 F L2 40 10 6 60
8 BS 62 F L1 30 22 10 45
9 MH 76 M L1 10 10 7 70
10 KH 45 M T10 7 20 9 45
11 HG 75 F L1 3 20 9 45
12 NK 71 M L2 11 12 8 67
13 HM 79 F T11 30 16 6 38
14 HE 75 M L2 10 10 6 60
15 FF 52 M T5 22 14 0 0
16 CE 72 F L3 2 10 10 100
17 MC 65 F L1 2 18 6 33
18 FH 58 M L4 4 8 7 88
19 WU 34 M L1 3 14 5 36
20 KH 66 M T12 20 28 18 64
21 KR 77 F T12 90 17 8 47
22 FE 61 F L1 4 20 17 85
23 SE 53 F T12 40 36 12 34
24 ZC 63 M L1 16 22 10 45
25 SW 55 M L1 7 22 10 45
26 BA 74 F L1 7 16 10 63
27 PN 71 F L1 60 26 18 69
treated level, fracture age and pre-operative kyphosis) as predic-
tors of the final achieved fracture reduction. A stepwise, forward-
selection, multiple regression analysis was computed with fracture
correction as the dependent variable, using Statistica 6.0 soft-
ware (StatSoft, Tulsa, OK, USA), with a significance level set at
p =0.05.
Results
Twenty-one patients had sustained fractures on the basis
of a primary osteoporosis with minimal trauma. The aver-
age age in this group was 68 years. Two younger patients
suffered from Bechterew’s disease (no. 10, KH, age 45)
and osteogenesis imperfecta respectively (no. 19, WU,
age 34). One additional patient suffered from steroid-in-
duced secondary osteoporosis (no. 20, KH, age 66). The
same patient had to be treated surgically for a bleeding
ulcer two days post kyphoplasty. All other interventions
were performed without any perioperative or postopera-
tive complications.
Local cement leaks were observed in nine vertebrae (in
three patients towards the disc space and in six patients
lateral to the vertebral body). None of these findings
seemed to have clinical sequelae. During follow-up, the
cement plug seemed to have shifted anteriorly in one ver-
tebra, but no loss of reduction or pathological movement
could be detected.
All patients could be mobilised within the first 24 h 
after surgery. Twenty-one patients were hospitalised for
1–3 days. Due to additional injuries, three patients stayed
for a maximum of 11 days. In 16 cases kyphoplasty was
performed as an isolated procedure, whereas in 8 patients
the adjacent levels above and below the kyphoplasty were
reinforced with vertebroplasty during the same surgery.
Indications for a combined procedure were advanced
stage of osteoporosis as well as significant overall kypho-
sis of the segments to be treated.
Two patients needed further spine interventions during
the one-year follow-up. In one (no. 5, SH), kyphoplasty at
T12 failed to relieve the pain and a dorsal stabilisation at
L4–S1 was performed due to significant degenerative
changes. In that case the VAS data at the latest follow-up
was disregarded. In one case (no. 20, KH), an additional
fracture developed cranial to the initially treated level T12
and a two-level vertebroplasty was performed at T10 and
T11 (Fig. 1).
All but one patient experienced pain relief following
kyphoplasty (Table 2), which was neither related to the
level treated nor to the amount of reduction achieved. In
two cases early in this series, significant improvement was
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Fig. 1A–G Representative
case (no. 20, KH). A Pre-oper-
ative situation with severely
painful fractures of T12 and
L1. Kyphotic deformity of
T12=28°. B Treatment of T12
with kyphoplasty and conven-
tional vertebroplasty of L1.
Important correction of T12
with 18° immediately postop-
erative, and absolute disap-
pearance of the pain. C Acute
recurrence of pain after 1 week;
a fracture of the adjacent ver-
tebra (T11) was observed 
(arrows) on the X-ray. D The
patient was treated successfully
with a conventional vertebro-
plasty on T11 and T10 that
was injected in a prophylactic
sense. E–G The course was
uneventful with mild pain. The
follow-up X-rays after 2 years
show a stable situation with 
no sintering of the reinforced
bones and no loss of the initial
reduction
noted at the 2 month follow-up, whereas 21 patients re-
ported an immediate change. After one year, a constant
score on VAS was noted by 17 patients, with a further im-
provement noted by 4 patients. However, one of them
(no. 20, KH) had received further vertebroplasties due to
adjacent segment pathology during follow-up.
Two patients reported deterioration; one of them (no. 11,
HG) with a minimal change of score from “1” at 2 months
follow-up to “2” after one year. The other patient (no. 15,
FF) had exacerbated pain one year following kyphoplasty
at T5. Further interventions were suggested to address the
thoracic kyphosis caudal to the treated level, but the pa-
tient refused. An acute fracture could not be observed at
this stage.
In this series, kyphoplasty achieved a 47.7% average
improvement of local bony kyphosis. A loss of reduction
after one year was not seen in any case. In 4 of 27 verte-
bral bodies no or minimal reduction was measured (<20%
change). These fractures were located at T5 (one case) or
were older than 40 days. In fractures aged 40 days and
younger, reduction was possible by 54.6%. In fractures
older than 40 days, a change of 35.8% was measured.
Stepwise multiple regression resulted in the following
regression formula: FC= –12.571 + 0.553 PK + 0.625 L –
0.037 FA + 0.070 A, r2 =0.651, p <0.0001. FC is the frac-
ture correction in degrees, PK is the pre-operative kypho-
sis in degrees, L is the treated level, numbered sequen-
tially from 1° at T1 to 17° at L5, FA is the fracture age in
days and A is the patient age in years. Significant factors
were pre-operative kyphosis (p <0.0001), treated level
(p =0.035) and fracture age (p =0.046). Patient age was
not a significant predictor (p =0.279), but inclusion im-
proved the overall predictive power of the regression
analysis.
Discussion
Osteoporotic VBCFs are a major cause of back pain in the
elderly. Even though only about one third of all fractures
come to clinical attention, the sequelae of VBCFs repre-
sent a major impact on patients’ physical function, quality
of life, and survival. As our population ages, the rate of
osteoporotic fractures is expected to triple over the next
30 years [21].
An ideal treatment for VBCFs should relieve fracture-
related pain and durably correct the kyphotic deformity of
the spinal segment. Vertebroplasty involving the percuta-
neous injection of polymethylmethacrylate (PMMA) into
the vertebral body results in substantial pain relief in the
majority of patients, which has led to this technique 
becoming very popular in the treatment of VBCFs [5].
Kyphoplasty seems to achieve at least comparable results,
with pain improvement reported in 95% of cases [7, 12].
The reduction of pain directly contributes to improve-
ments in quality of life and the ability to move indepen-
dently [12].
We can confirm these results, as all but one patient in
our series benefited from the procedure, and the effect
was maintained at the one-year follow-up. The amount of
reduction in deformity however, was not related to the de-
gree of pain relief. The one failure case early in our expe-
rience was probably due to incomplete pre-operative work-
up, as the treated deformity was old and there were con-
siderable further sources of pain in the lower back. Most
of our patients now undergo additional pre-operative
imaging, as MRI can document bone marrow edema as a
sign of recent fracture and thereby select candidates for
the procedure [23].
Recent biomechanical investigations have increased
concerns about an increased fracture risk of adjacent non-
augmented levels following vertebroplasty [2]. In a clini-
cal series, Grados et al. [8] found that 13 out of 25 patients
treated with vertebroplasty (52%) developed a total of 34
new vertebral fractures after a mean follow-up of 48 months.
Another study with a two-year follow-up reported a
12.4% rate of new fractures, two-thirds of which were di-
rectly adjacent to the previously treated level [22]. In our
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Table 2 Pain score as given on VAS (1–10), pre-operatively and
at follow-ups. For average values, one patient counts as a single
procedure
No Pat Pre-op Post-op 2Mo 1Y
1 WY 9 8 3 3
2 WY 9 8 3 3
3 HE 5 4 1 1
4 HE 5 4 1 1
5 SH 7 7 – –
6 StH 8 1 1 0
7 StH 8 1 1 0
8 BS 10 5 1 1
9 MH 9 2 0 0
10 KH 10 0 – 0
11 HG 8 2 1 2
12 NK 3 0 0 0
13 HM 9 1 0 0
14 HE 9 2 1 1
15 FF 10 5 5 8
16 CE 10 6 4 4
17 MC 8 4 1 1
18 FH 9 3 2 1
19 WU 6 3 2 0
20 KH 8 4 4 1
21 KR 9 2 2 2
22 FE 10 0 0 0
23 SE 10 6 2 2
24 ZC 9 5 2 2
25 SW 9 5 3 3
26 BA 7 2 0 0
27 PN 10 4 3 3
Av 8.4 3.8 1.7 1.5
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kyphoplasty series, we observed only one adjacent verte-
bral fracture in 24 patients, but the follow-up was shorter.
From our data, it is too early to conclude whether the risk
of adjacent fractures is different following kyphoplasty as
compared to vertebroplasty.
Safety issues of vertebroplasty have increasingly be-
come a matter of discussion. Forcible injection of low-
viscosity cement is necessary to inject the cement along
small diameter tubes and cannulas, leading to cement
leakage from the vertebral body in up to 65% of osteo-
porotic fractures [4]. Serious complications such as pul-
monary embolism and paraplegia are rare, but have been
reported [10, 13, 15]. Kyphoplasty seems to lower the risk
of extravertebral cement leak, as it allows a vertebral cav-
ity to be filled with more viscous cement [14].
In a study of 30 patients treated with kyphoplasty at 70
levels, Lieberman et al. [14] reported minor cement leak-
age at six levels (8.6%). Ledlie and Renfro [12] recorded
12 PMMA leaks during the repair of 133 fractures (9%).
Particularly early in our experience we intended to aug-
ment the entire vertebral body rather than only fill the
cavity left by the balloon. Vertebroplasty was initially
done under higher cement injection pressures, leading to a
relatively large rate of (minor) cement leaks (33%). How-
ever, no clinically relevant cement extrusions were ob-
served.
Vertebroplasty focuses on prevention of further verte-
bral collapse. With the exception of very fresh fractures
and mobile pseudarthroses, which might respond to a hy-
perlordotic positioning of the patient on the operating
table, a reduction of the deformity does not seem possible.
Kyphoplasty has shown the potential to achieve at least
partial restoration of vertebral height. In our series, an av-
erage improvement of 47.7% of local bony kyphosis was
measured. This is within the range of other publications.
Lieberman et al. reported a mean vertebral body height
restoration of 46.8% [14]. Garfin et al. stated that kypho-
plasty improves kyphosis by over 50%, if performed
within 3 months of the onset of the fracture [7].
In single cases of very fresh fractures, a height reduc-
tion may also be possible by a hyperlordotic positioning
of the patient alone, but this potential seems very limited
and was not generally seen in this case series. Our data
also supports the conclusion that the potential for reduc-
tion is time-related. Pre-operative MRI investigation in
cases of unclear fracture age may therefore be helpful to
determine the potential benefit of kyphoplasty procedures.
The ability to restore vertebral height also improves
with the amount of pre-operative kyphosis and more cau-
dally located levels. Whether the latter is due to a more
favourable relationship between cortical and cancellous
bone remains to be discussed.
Conclusion
The treatment of osteoporotic VBCFs with kyphoplasty
reliably reduced pain soon after surgery and at the one-
year follow up. A 50% average improvement of local
kyphosis was possible, with even more potential for re-
duction in fractures younger than 6 weeks. After one year,
no loss of reduction was seen. However, the specific ef-
fect of height restoration and spinal realignment on the
long-term clinical outcome and general parameters such
as life quality and mortality of the patients remains to be
investigated.
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